GM Advisory Group LLC decreased its position in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 5.9% in the fourth quarter, HoldingsChannel reports. The fund owned 83,757 shares of the company’s stock after selling 5,256 shares during the quarter. GM Advisory Group LLC’s holdings in HealthEquity were worth $8,036,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Harvest Fund Management Co. Ltd purchased a new stake in HealthEquity during the fourth quarter valued at approximately $512,000. Xponance Inc. increased its stake in HealthEquity by 6.2% during the 4th quarter. Xponance Inc. now owns 12,276 shares of the company’s stock valued at $1,178,000 after purchasing an additional 718 shares in the last quarter. Intech Investment Management LLC increased its stake in HealthEquity by 55.0% during the 4th quarter. Intech Investment Management LLC now owns 32,650 shares of the company’s stock valued at $3,133,000 after purchasing an additional 11,586 shares in the last quarter. Thrivent Financial for Lutherans increased its stake in HealthEquity by 15.9% during the 4th quarter. Thrivent Financial for Lutherans now owns 340,297 shares of the company’s stock valued at $32,652,000 after purchasing an additional 46,673 shares in the last quarter. Finally, Cibc World Markets Corp acquired a new position in HealthEquity during the 4th quarter valued at approximately $770,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.
Insider Buying and Selling at HealthEquity
In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the transaction, the director now owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 2.20% of the stock is owned by corporate insiders.
HealthEquity Stock Up 0.9 %
Analyst Upgrades and Downgrades
A number of research analysts have issued reports on the stock. Royal Bank of Canada upped their price target on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. Mizuho assumed coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target on the stock. Barrington Research restated an “outperform” rating and set a $112.00 price target on shares of HealthEquity in a research note on Friday, March 14th. Wells Fargo & Company increased their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 26th. Finally, Raymond James raised their target price on shares of HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a report on Tuesday, February 25th. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $112.92.
Get Our Latest Report on HealthEquity
HealthEquity Company Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Stories
- Five stocks we like better than HealthEquity
- Overbought Stocks Explained: Should You Trade Them?
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- What is Insider Trading? What You Can Learn from Insider Trading
- 3 Must-Own Stocks to Build Wealth This Decade
- How to Most Effectively Use the MarketBeat Earnings Screener
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.